Strategy

Oct 31, 2016
Michael Gordon charts the evolution of regulatory operations and suggests how it can spearhead opportunities for innovation in pharma data.
Sep 23, 2016
The secret sauce for creating blockbuster brands has always been — and always will be — consistently exceptional team execution. Andy Mehrotra offers the recipe.
May 31, 2016
For those willing to invest in the right capabilities, offering patient services can give pharma companies a tremendous opportunity.
May 16, 2016
Payers, providers, patients and pharma companies all want to understand the value of specific treatments – and patient registries can help them do that.
May 02, 2016
As companies look to raise capital, selling and then leasing back real estate is a tempting option and one that other industries are utilizing, writes Karen Williamson.
Apr 26, 2016
The liver disease NASH has become a priority for the healthcare industry – and, potentially, a multi-billion-dollar market.
Apr 01, 2016
Peter Young examines the drivers affecting the biotech industry in 2015, and what to expect in 2016.
Mar 28, 2016
Intense regulatory demands, cost pressure, and the need to be ever more efficient has led to an upturn in the use of management consultants in the pharma & biotech sector, writes B.J. Richards.
Mar 24, 2016
Several factors are combining to change the definition of what healthcare truly is, and how it will be delivered and experienced in the next few years.
Mar 11, 2016
Pharmaceutical Executive
Positioning for success in biopharma requires a self-critical analysis of the risk and rewards among four categories of value differentiation. The key question: How do you define yourself against the competition?
native1_300x100
lorem ipsum